Please login to the form below

Not currently logged in

future of pharma

This page shows the latest future of pharma news and features for those working in and with pharma, biotech and healthcare.

ABPI explores the future of medicines

ABPI explores the future of medicines

the user on a 360-degree journey into the world of breakthrough medicine. ... Jay Short, business and sales director at INITION, said: “We have been privileged to see that the ABPI has big ideas as to how the future could look for the pharmaceutical

Latest news

  • The shifting healthcare landscape The shifting healthcare landscape

    reputation. The role of comms in pharma’s future. Sharpen social media approach and attract new partners. ... The future of pharma lies in being far more active in creating new approaches and turning ‘we can’t’ into ‘what if we could’.

  • Jeux sans frontières Jeux sans frontières

    Here at PMLiVE we began this year anticipating a year of change for pharma and, sure enough, we end the year knowing where the EMA is headed. ... That’s particularly true if we try to guess the future shape of UK-EU pharma regulatory relations and the

  • Adopting a creative IP approach towards biotech clusters Adopting a creative IP approach towards biotech clusters

    Why big pharma paradigm needs to change. In recent years biotech clusters have become an increasingly important part of pharmaceutical companies’ research and development strategies. ... development. Given this trend and the benefits we are already

  • NICE: We're the institute of 'yes' NICE: We're the institute of 'yes'

    QuintilesIMS' Question Time: The Future of of Pharma and Life Sciences in the UK meeting came just one week after the publication of Sir John Bells' Life Sciences Industrial Strategy report. ... There will be a full report on QuintilesIMS' Question

  • Millennials and health Millennials and health

    Hope in science, but loathing of pharma. As a generation, millennials are positive and optimistic, and they embrace the future. ... Many millennials feel pharma profits should be capped and the excess forced back into future R&D efforts or subsidising

More from news
Approximately 1 fully matching, plus 52 partially matching documents found.

Latest Intelligence

  • The future of medicine has to be data-driven The future of medicine has to be data-driven

    What makes this technology challenging is both the complexity and quantity of the data that is produced. ... The future of medicine has to be data-driven. We need to work together, across national and organisational borders, break down information silos

  • Brexit Means Brexit Brexit Means Brexit

    The shape of pharma’s future is, very much like this article, a hostage to negotiations that may ultimately puncture the balloon of optimism. ... Yet despite the enormity of what is at stake, pharma must remain pragmatic and flexible.

  • Pulling together Pulling together

    Also speaking at the QuintilesIMS’ The Future of Pharma and Life Sciences in the UK debate was Ben Howlett. ... Now’s the time. Looking to the future Professor Keith McNeil, NHS chief clinical information officer, operations and information at NHS

  • The Future of Marketing in Life Sciences: Is your function fit for purpose The Future of Marketing in Life Sciences: Is your function fit for purpose

    What does the Life Sciences marketing capability of the future look like? ... Join EY (a global leader in assurance, tax, transaction and advisory services) in association with PMGroup to discuss the future of marketing in Life Sciences.

  • Dispensing with the past Dispensing with the past

    The pharma boards of the future. To be successful in the changing healthcare environment, pharmaceutical companies need an honest self-assessment. ... Recent global research undertaken by Russell Reynolds Associates (RRA) examines the questions of

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

  • EUSA Pharma founder to chair Glide Pharma EUSA Pharma founder to chair Glide Pharma

    Morton was most recently chief executive at oncology specialist EUSA Pharma – a company he also founded. ... Commenting on the future of Glide Pharma under his direction Morton said: "Having completed a significant investment round earlier this year

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Making a Difference - The Future of Pharma

    On a global scale, pharma is one of the least-trusted industries. ... Pharma companies today have the unique opportunity to redefine their role: from providers of commodities to our healthcare system to valued partners in delivering outstanding patient

  • Attracting and retaining talent – recruiting the workforce of the future

    Its latest research report uncovered four trends that are shaping the future of work. ... Technology will continue to enable flexibility. To become an employer of choice, with the ability to attract a more skilled workforce, companies need to embrace

  • What does a future-proof rep look like?

    The future is bright. The next generation of pharma sales reps won’t follow a ‘one size fits all’ mentality. ... OUTiCO RECRUITING NOW! We are hiring exceptional pharma sales professionals to join our team of Multi-Channel Account Managers.

  • Biotech: it's a people business

    Biologic therapies have become a central part of modern day medicine and a key part of biotech and pharma portfolios. ... From Johnson &Johnson’s immunology treatments to Pfizer’s work on a stem cell-based remedy for age-related macular degeneration,

  • Pharma Social Media Ranking - Global Twitter Edition 2018

    This 2018 pharma social media ranking from healthcare agency Owen Health provides a snapshot of the performance of 22 of the largest pharma companies on Twitter. ... Even back in 2014 eyeforpharma’s Industry Healthcheck found that 75% of pharma

More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...